• Explore /
  • Poster
  • / Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study.

Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study.

Abstract Poster

Authors

Edmond Kwan

Edmond Michael Kwan

BC Cancer, Vancouver Centre, Vancouver, BC, Canada

Edmond Michael Kwan , Moira Katherine Rushton , Wilson Tu , Sebastien J. Hotte , Som D. Mukherjee , Michael Ong , Michael Paul Kolinsky , Zineb Hamilou , Eric Winquist , Cristiano Ferrario , Robyn Jane Macfarlane , Fred Saad , Muhammad Salim , Di Maria Jiang , Dongsheng Tu , James Hutchenreuther , Matti Annala , Lesley Seymour , Kim N. Chi , Alexander William Wyatt

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT02905318, NCT03385655

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 218)

DOI

10.1200/JCO.2023.41.6_suppl.218

Abstract #

218

Poster Bd #

H6

Abstract Disclosures

Similar Posters

First Author: Kim N. Chi

First Author: Neeraj Agarwal

First Author: Richard Gagnon

Poster

2019 Genitourinary Cancers Symposium

Genomic changes of <em>AR</em> in ctDNA prior to enzalutamide in men with mCRPC after abiraterone acetate.

Genomic changes of AR in ctDNA prior to enzalutamide in men with mCRPC after abiraterone acetate.

First Author: Leta Ko